ifosfamide has been researched along with Glioblastoma with Sarcomatous Component in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The in vivo modulation of these alternative, competing pathways of P-450 metabolism was investigated in pharmacokinetic studies carried out in the rat model." | 1.30 | In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity. ( Brain, EG; Drewes, P; Gustafsson, K; Hecht, JE; Waxman, DJ; Yu, LJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L | 1 |
| Waxman, DJ | 3 |
| Jounaidi, Y | 1 |
| Hecht, JE | 2 |
| Yu, LJ | 1 |
| Drewes, P | 1 |
| Gustafsson, K | 1 |
| Brain, EG | 1 |
3 other studies available for ifosfamide and Glioblastoma with Sarcomatous Component
| Article | Year |
|---|---|
Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; beta-Galactosidase; Biotransformation; Cell Line; Cell Survi | 1995 |
Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy.
Topics: Animals; Antineoplastic Agents; Clone Cells; Cyclophosphamide; Cytochrome P-450 CYP2B1; Cytochrome P | 1998 |
In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Brain Neoplasms; Cyclophosphamide; Cytochrome P-45 | 1999 |